SCHEMBL11522682

SCHEMBL11522682

CC1CCCC(N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23347485 1.00 CYP2C9 (0.30)
SCHEMBL29342017 1.00 CYP2C9 (0.30)
SCHEMBL22680724 1.00
SCHEMBL23222175 1.00
SCHEMBL19309258 0.97 CYP2C9 (0.32)
SCHEMBL6396771 0.94 THRB (0.35)
SCHEMBL22340337 0.94 THRB (0.35)
SCHEMBL13697414 0.94 CYP2C9 (0.33)
SCHEMBL18616053 0.94 CYP2C9 (0.33)
SCHEMBL13697412 0.94 CYP2C9 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3421549-B1 COLORING COMPOSITION, INKJET RECORDING INK, INKJET RECORDING METHOD, AND INKJET PRINTER CARTRIDGE FUJIFILM CORP (JP) 2023-08-16 EP disclosed
WO-2023081730-A1 4-HYDROXY-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE DERIVATIVES AS CANNABINOID CB2 RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER TEON THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed
WO-2023016521-A1 SUBSTITUTED TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 上海赛默罗生物科技有限公司 2023-02-16 WO disclosed
EP-4047020-A1 HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT Numab Therapeutics AG (CH) 2022-08-24 EP disclosed
US-10766800-B2 Removal of nitrates from ground water TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2020-09-08 US disclosed
EP-3019480-B1 2,4- OR 4,6-DIAMINOPYRIMIDINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER AGIOS PHARMACEUTICALS INC (US) 2020-05-06 EP disclosed
US-20190309013-A1 LINKER MOLECULE AND USE THEREOF IN METHODS FOR PURIFYING PEPTIDES Belyntic GmbH (DE) 2019-10-10 US disclosed
EP-3351551-A1 PREPARATION METHOD OF NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS AND INTERMEDIATES THEREOF BrightGene Bio-Medical Technology Co., Ltd. (CN) 2018-07-25 EP disclosed
WO-2018071314-A1 TRICYCLIC SULFONES AS ROR GAMMA MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-04-19 WO disclosed
EP-2365555-B1 Organic light-emitting device and method of manufacturing the same SAMSUNG DISPLAY CO LTD (KR) 2017-11-15 EP disclosed
EP-3127965-A1 AZO COMPOUND, DYE-BASED POLARIZING FILM CONTAINING SAME, AND POLARIZING PLATE Nippon Kayaku Kabushiki Kaisha (JP) 2017-02-08 EP disclosed
US-4174351-A Separation of dissimilar amines UOP INC. (US) 1979-11-13 US disclosed